Kevin McGrath is the current Chief Operating Officer for Tevogen, a specialty pharmaceutical company focused on gene and cell therapeutics. He has over 25 years of recruitment experience and has an intimate knowledge of trends that are occurring around the industry. Prior to moving to an Advisory Board role with Penfield, Kevin was a Principal leading one of the Pharmaceutical Practices. He had worked previously with Smith Hanley Associates and its parent company inVentiv Health. Kevin has a BA in History from Princeton University.